McConnell: GOP has 'internal divisions' on bill to lower drug prices

McConnell: GOP has 'internal divisions' on bill to lower drug prices
© Bonnie Cash

Senate Majority Leader Mitch McConnellAddison (Mitch) Mitchell McConnellGraham: GOP will confirm Trump's Supreme Court nominee before the election Trump puts Supreme Court fight at center of Ohio rally The Memo: Dems face balancing act on SCOTUS fight MORE (R-Ky.) on Tuesday said Senate Republicans have “internal divisions” on a bill to lower drug prices and that he does not know yet whether the measure will get a vote. 

Senate Finance Committee Chairman Chuck GrassleyCharles (Chuck) Ernest GrassleyGardner signals support for taking up Supreme Court nominee this year Grassley, Ernst pledge to 'evaluate' Trump's Supreme Court nominee McConnell digs in on vow to fill Ginsburg's Supreme Court seat MORE (R-Iowa) for months has been calling for action on his bipartisan bill to lower drug prices with Sen. Ron WydenRonald (Ron) Lee WydenGOP set to release controversial Biden report Democrats fear Russia interference could spoil bid to retake Senate GOP senator blocks Schumer resolution aimed at Biden probe as tensions run high MORE (D-Ore.), noting that it is also backed by the White House and could help vulnerable Republicans in their reelection campaigns. 

When asked whether he would bring the bill to the floor, McConnell told reporters there are “internal divisions within my party in the Senate” that must be resolved on both that bill and another health care measure aimed at protecting patients from surprise medical bills. 

ADVERTISEMENT

“I think everybody agrees that prescription drug prices are too high,” McConnell said. “The dilemma is how do you get there, and we have divisions within the Republican Party on that and with the Democrats on that. So, yeah, we're going to be talking about it. Whether we can all pull together and get a solution, I'm not prepared to predict today.”

Many Senate Republicans have objected to Grassley’s bill, particularly a provision that would limit drug price increases in Medicare to the rate of inflation, something some Republicans view as a “price control.”

But Grassley is pointing to the popularity with voters of addressing high drug prices. Sen. Martha McSallyMartha Elizabeth McSallyTumultuous court battle upends fight for Senate Grassley, Ernst pledge to 'evaluate' Trump's Supreme Court nominee The Hill's Campaign Report: Biden goes on offense MORE (R-Ariz.), who faces a tough campaign this year, endorsed the bill on Monday, giving a boost to the effort. 

The White House also supports the bill. President TrumpDonald John TrumpBubba Wallace to be driver of Michael Jordan, Denny Hamlin NASCAR team Graham: GOP will confirm Trump's Supreme Court nominee before the election Southwest Airlines, unions call for six-month extension of government aid MORE in his State of the Union address earlier this month praised Grassley for his work on drug prices.

McConnell noted that the issue will be at the center of negotiations ahead of a May 22 deadline for renewing expiring health programs such as community health centers. Backers hope both drug pricing and surprise medical billing legislation could be attached to legislation that needs to move ahead of that deadline. 

ADVERTISEMENT

Another question mark is House Speaker Nancy PelosiNancy PelosiTrump puts Supreme Court fight at center of Ohio rally CDC causes new storm by pulling coronavirus guidance Overnight Health Care: CDC pulls revised guidance on coronavirus | Government watchdog finds supply shortages are harming US response | As virus pummels US, Europe sees its own spike MORE (D-Calif.), who is pushing for a more aggressive bill to lower drug prices by allowing the government to negotiate prices, but that measure has been widely dismissed by Republicans. 

As such, Grassley pitches his bill as a compromise. 

"I’m confident that if this bill were brought up for a vote, it would pass overwhelmingly," he said on the floor Tuesday. "Let’s not miss an opportunity to deliver real progress for Americans."